세계의 혈행동태 모니터링 시스템 시장 규모는 2023년에 9억 2,400만 달러여, 2030년까지 13억 3,000만 달러에 달할 것으로 예측되며, 2024-2030년의 예측 기간에 CAGR로 6.29%의 성장이 전망됩니다. 심부전 및 고혈압과 같은 심혈관 질환의 유병률 증가는 이러한 질환을 효과적으로 관리하고 환자의 결과를 개선하기 위해 지속적 이고 정확한 모니터링의 필요성을 강력하게 보여줍니다. 동시에 환자와 의료진 모두 건강에 대한 인식이 높아지면서 조기 발견과 개입을 가능하게 하는 첨단 모니터링 솔루션에 대한 수요가 증가하고 있습니다. 또한 센서 강화 및 전자건강기록과의 통합과 같은 기술 혁신을 특징으로 하는 시장 주요 업체들의 제품 개발이 증가함에 따라 보다 정밀하고 사용하기 쉽고 통합된 모니터링 솔루션을 제공함으로써 시장 성장을 더욱 촉진하고 있습니다. 이러한 요인들이 결합되어 혈행동태 모니터링 시스템의 채택 확대와 발전에 기여하여 2024-2030년의 예측 기간 중 시장 성장을 가속할 것으로 예상됩니다.
혈액역학 모니터링 시스템 시장 역학
British Heart Foundation의 최근 데이터(2024년)에 따르면 전 세계에서 약 6억 2,000만 명, 약 13명 중 1명이 심장 및 순환기 질환을 앓고 있습니다. 또한 이 자료에 따르면 2021년 심장 및 순환기 질환 유병률은 유럽에서 1억 명, 아시아-호주에서 3억 4,000만 명에 달할 전망입니다.
또한 영국심장재단(British Heart Foundation)의 최근 데이터(2024년)에 따르면 관상동맥(허혈성) 심장질환은 전 세계에서 가장 많이 진단되는 질환으로, 전 세계에서 약 2억 명이 앓고 있는 것으로 추산됩니다. 약 1억 1,000만 명의 남성과 8,000만 명의 여성이 이 질환을 앓고 있습니다. 또한 약 5,600만 명의 여성과 4,500만 명의 남성이 뇌졸중 생존자입니다. 전 세계에서 최소 1,300만 명이 선천성 심장질환을 앓고 있는 것으로 추정되며, 수백만 명은 아직 진단되지 않은 것으로 추정됩니다.
세계보건기구(WHO)의 최신 데이터(2023년)에 따르면 전 세계 30세에서 79세 사이의 성인 고혈압 환자는 약 12억 8,000만 명으로 추산되며, 이들 중 대부분(3분의 2)은 중저소득 국가에 거주하고 있습니다. 고혈압을 앓고 있는 성인의 약 46%는 자신의 상태를 인지하지 못하고 있으며, 절반 이하(42%)만이 진단을 받고 치료를 받고 있는 것으로 나타났습니다. 심장병, 심부전, 고혈압과 같은 심혈관 질환이 전 세계에서 유행함에 따라 환자의 심혈관 건강 상태를 실시간으로 파악할 수 있는 첨단 모니터링 솔루션에 대한 수요가 증가하고 있습니다. 혈행동태 모니터링 시스템은 혈압, 심박출량, 체액 상태와 같은 주요 생리적 매개변수를 추적하는 중요한 기능을 제공합니다. 이러한 시스템은 임상의가 혈행동태 변화를 신속하고 정확하게 모니터링할 수 있게 함으로써 치료 계획을 최적화하고 합병증을 예방하며 전체 환자 결과를 개선하는 데 도움을 주어 전 세계 혈행동태 모니터링 시스템 시장을 확대시키고 있습니다.
상기 요인 외에도 수율과 진단 정확도를 향상시키는 신기술 개발 등 혈행동태 모니터링 시스템 분야의 기술 발전도 혈행동태 모니터링 시스템 시장의 성장에 도움이 될 것으로 예상됩니다. 예를 들어 2021년 9월 FDA는 Caretaker Medical의 VitalStream(TM) 무선 플랫폼을 비침습적 혈압 및 혈행동태 연속 모니터링에 사용할 수 있도록 승인했습니다.
그러나 패혈증, 출혈, 혈전증, 정확성에 대한 우려 등 침습적 혈행동태 모니터링에 따른 위험은 혈행동태 모니터링 시스템의 성장을 억제할 것으로 예상됩니다.
혈액역학 모니터링 시스템 시장 부문 분석
전체 혈행동태 모니터링 시스템 시장의 제품 부문에서 비침습적 혈행동태 모니터링 시스템은 2023년에 가장 큰 점유율을 차지할 것으로 예측됩니다. 비침습적 혈행동태 모니터는 환자의 편의성을 높이고, 임상 결과를 개선하며, 의료 워크플로우를 간소화하는 첨단 솔루션을 제공함으로써 전체 혈행동태 모니터링 시스템 시장을 크게 견인하고 있습니다. 이러한 모니터는 침습적 시술 없이도 정확하고 지속적인 혈행동태 데이터를 제공함으로써 환자의 위험을 줄이고 불편함을 최소화하며 합병증 발생 가능성을 낮춥니다. 그 결과, 응급의료 및 일상적인 환자 모니터링과 같은 다양한 임상 환경에서 점점 더 선호되고 있습니다. 비침습적 모니터는 혈압, 심박출량, 체액 상태와 같은 중요한 매개변수에 대한 데이터를 실시간으로 제공함으로써 의료진이 적시에 정보에 입각한 의사결정을 내릴 수 있으며, 치료 전략을 최적화하고 환자 관리를 개선할 수 있도록 돕습니다.
세계의 혈행동태 모니터링 시스템 시장에 대해 조사분석했으며, 각 지역의 시장 규모와 예측, 과거 3년 제품/기술개발, 시장의 주요 기업, 향후 기회등의 정보를 제공하고 있습니다.
Hemodynamic Monitoring Systems Market by Product (Systems and Disposables), Type (Invasive Hemodynamic Monitoring, Minimally Invasive Hemodynamic Monitoring, and Non-Invasive Hemodynamic Monitoring), End-User (Hospitals, Ambulatory Care Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increase in incidence of cardiovascular diseases, growing awareness regarding health, and increase in product development activities by key market players across the globe.
The global hemodynamic monitoring systems market was valued at USD 924 million in 2023, growing at a CAGR of 6.29% during the forecast period from 2024 to 2030, in order to reach USD 1.33 billion by 2030. The growing prevalence of cardiovascular conditions, such as heart failure and hypertension, underscores the need for continuous and accurate monitoring to manage these diseases effectively and improve patient outcomes. Concurrently, heightened health awareness among both patients and healthcare providers drives demand for advanced monitoring solutions that enable early detection and intervention. Furthermore, increased product development by key market players characterized by technological innovations, such as enhanced sensors and integration with electronic health records, further propels market growth by offering more precise, user-friendly, and integrated monitoring solutions. Together, these factors contribute to the expanding adoption and advancement of hemodynamic monitoring systems and propels market growth during forecast period from 2024 to 2030.
Hemodynamic Monitoring Systems Market Dynamics:
According to a recent data provided by British Heart Foundation (2024), globally, approximately 620 million people, or about 1 in 13 individuals, lived with heart and circulatory diseases. Additionally, as per the same source, the prevalence of heart and circulatory diseases was 100 million in Europe and 340 million in Asia and Australia in 2021.
Furthermore, as per the recent data provided by the British Heart Foundation (2024), coronary (ischemic) heart disease, was the most commonly diagnosed worldwide, affected an estimated 200 million people globally. Approximately 110 million men and 80 million women were affected. Additionally, around 56 million women and 45 million men were stroke survivors. It was estimated that at least 13 million people worldwide lived with congenital heart disease, with potentially millions more undiagnosed.
As per the latest data provided by World Health Organization (2023), an estimated 1.28 billion adults aged 30-79 years worldwide had hypertension, with most (two-thirds) residing in low- and middle-income countries. An estimated 46% of adults with hypertension were unaware of their condition, and less than half (42%) had been diagnosed and treated. As cardiovascular conditions, such as heart disease, heart failure, and hypertension, become more prevalent globally, there is an increased demand for sophisticated monitoring solutions that can provide real-time insights into patients' cardiovascular health. Hemodynamic monitoring systems offer vital capabilities to track key physiological parameters, such as blood pressure, cardiac output, and fluid status, which are crucial for diagnosing, treating, and managing these conditions. By enabling clinicians to monitor changes in hemodynamic status promptly and accurately, these systems help in optimizing treatment plans, preventing complications, and improving overall patient outcomes thereby escalating the overall market of hemodynamic monitoring systems across the globe.
Along with the factors mentioned above, technological advancements in the field of hemodynamic monitoring systems such as the development of new techniques to enhance the yield and diagnostic accuracy are also expected to aid in the growth of the hemodynamic monitoring systems market. For instance, in September 2021, FDA cleared Caretaker Medical's VitalStream(TM) wireless platform for continuous noninvasive blood pressure and hemodynamic monitoring.
However, the risk associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, and accuracy concerns is expected to restrain the growth of hemodynamic monitoring systems.
Hemodynamic Monitoring Systems Market Segment Analysis:
Hemodynamic Monitoring Systems Market by Product (Systems and Disposables), Type (Invasive Hemodynamic Monitoring, Minimally Invasive Hemodynamic Monitoring, and Non-Invasive Hemodynamic Monitoring), End-User (Hospitals, Ambulatory Care Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product segment of the overall hemodynamic monitoring systems market, the non-invasive hemodynamic monitoring systems are expected to hold the largest share in the year 2023. Non-invasive hemodynamic monitors are significantly boosting the overall market for hemodynamic monitoring systems by offering advanced solutions that enhance patient comfort, improve clinical outcomes, and streamline healthcare workflows. These monitors provide accurate and continuous hemodynamic data without the need for invasive procedures, which reduces patient risk, minimizes discomfort, and lowers the potential for complications. As a result, they are becoming increasingly preferred in various clinical settings, including critical care, emergency medicine, and routine patient monitoring. The ability of non-invasive monitors to deliver real-time data on critical parameters such as blood pressure, cardiac output, and fluid status enables healthcare providers to make timely and informed decisions, optimizing treatment strategies and improving patient management.
Consequently, the advancement and integration of these monitors into clinical practice are propelling the market growth by enhancing the overall effectiveness and efficiency of hemodynamic monitoring systems. For instance, in January 2024, Nanowear, a leader in healthcare-at-home remote diagnostics, announced that its nanotechnology-enabled wearable and software platform, SimpleSense(TM), received FDA 510(k) clearance for its novel AI-enabled Software-as-a-Medical Device (SaMD). As the first non-invasive, cuffless, continuous blood pressure monitor and diagnostic, SimpleSense-BP represented a significant advancement in clinical diagnostic management of hypertension, adding to the wearable platform's previously cleared cardiopulmonary diagnostics.
Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global hemodynamic monitoring systems market during the forecast period.
North America is expected to dominate the overall hemodynamic monitoring systems market:
Among all the regions, North America is expected to hold the largest share in the global hemodynamic monitoring systems market in 2023. Owing to significant growth factors such as growing prevalence of hypertension and cardiovascular diseases. Additionally, increasing health awareness, technological advancement in hemodynamic monitoring system, and rising government initiatives are expected to aid in the growth of the North American hemodynamic monitoring systems market during the forecast period from 2024 to 2030.
According to the latest data provided by the Centre for Disease Control and Prevention (2023), approximately, 48.1% population of adults age 18 and older in the United States are living with hypertension.
According to recent data from the Centers for Disease Control and Prevention (2024), approximately 4.9% of adults were diagnosed with coronary heart disease in 2022. Furthermore, by 2023, an estimated 12.1 million individuals in the United States were projected to have atrial fibrillation. Additionally, each year, over 795,000 people in the U.S. experience a stroke, with around 610,000 of these being first-time strokes. Notably, nearly 185,000 of these strokes, or about one in four, occur in individuals who have previously had a stroke.
These conditions necessitate precise and continuous monitoring to manage and mitigate the risks associated with cardiovascular events. As healthcare providers and patients seek effective tools to monitor heart function, blood pressure, and overall cardiovascular health, hemodynamic monitoring systems become essential. These systems provide critical insights into cardiovascular performance, enabling timely interventions and personalized treatment plans. Thus, the increasing burden of these diseases fuels the market of hemodynamic monitoring system as healthcare systems invest in advanced monitoring technologies to improve patient outcomes and manage chronic conditions effectively thereby escalating the market across the region.
Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for hemodynamic monitoring systems. For instance, in March 2021, FDA granted De Novo classification to Fifth Eye's continuous hemodynamic status monitoring tool. The analytic for hemodynamic instability tool can identify hemodynamic instability with 96% sensitivity and detect stable patients with 85% specificity. The product launches in the local markets correlate to a significant reduction in costs thereby making them affordable for end-users which in turn drives the product demand in the market.
Therefore, the interplay of above mentioned various factors in the region are expected to boost the North America hemodynamic monitoring systems market during the forecast period.
Hemodynamic Monitoring Systems Market Key Players:
Some of the key market players operating in the hemodynamic monitoring systems market include Edwards Lifesciences Corporation, Getinge AB, Deltex Medical Limited, ICU Medical, Inc., CNSystems Medizintechnik GmbH, Caretaker, LLC, Osypka Medical GmbH, Baxter International Inc. (Cheetah Medical, Inc.), Shenzhen Comen Medical Instruments Co., Ltd., General Meditech Inc., Dragerwerk AG & Co. KGaA, General Electric Company, Smiths Group, Transonic Systems Inc., EMTEL Sliwa sp. K, NIMedical, Masimo (LiDCO Group Plc), Nihon Kohden Corporation, Hemo Sapiens Inc., Koninklijke Philips N.V., and others.
Recent Developmental Activities in the Hemodynamic Monitoring Systems Market:
Key Takeaways From the Hemodynamic Monitoring Systems Market Report Study:
Target Audience who can be Benefited From This Hemodynamic Monitoring Systems Market Report Study:
Frequently Asked Questions for the Hemodynamic Monitoring Systems Market: